Clinical Trial Update: Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating thymosin alpha-1 for improving monocyte function in sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Thymosin alpha-1 (thymosin alpha-1)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Sepsis | Phase 4 | Status: COMPLETED